63
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes*

, , &
Pages 17-22 | Received 23 Dec 2004, Accepted 28 Feb 2005, Published online: 03 Aug 2009

References

  • Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130–137.
  • Tucker J, McGuire W. Epidemiology of preterm birth. BMJ 2004;329:675–678.
  • Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Invest 2004;11:427–437.
  • Lei H, Furth EE, Kalluri R, et al. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 1996;98:1971–1978.
  • Parry S, Strauss JF, 3rd. Premature rupture of the fetal membranes. N Engl J Med 1998;338: 663–670.
  • Fortunato SJ, Menon R, Bryant C, et al. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. Am J Obstet Gynecol 2000;182: 1468–1476.
  • Athanyde N, Romero R, Gomez R, et al. Matrix metallopro-teinase-9 in preterm and term human parturition. J Matern Fetal Med 1999;8:213–219.
  • Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinase-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174: 1371–1376
  • Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998;179:1248–1253.
  • Williams MA, Mittendorf R, Lieberman E, et al. Adverse infant outcomes associated with first-trimester vaginal bleed-ing. Obstet Gynecol 1991;78:14–18.
  • Salafia CM, Leipez-Zeno JA, Sherer DM, et al. Histological evidence of old uterine bleeding is more frequent in prematurity. Am J Obstet Gynecol 1995;173:1065–1070.
  • Lockwood CJ, Nemerson Y, Guller S, et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Chin Endocrinol Metab 1993;76:231–236.
  • Lockwood CJ, Krikun G, Schatz F. Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann NY Acad Sci 2001;943:77–88.
  • Sere KM, Hackeng TM. Basic mechanisms of hemostasis. Sem Vasc Med 2003;3:3–1.
  • Anrather D, Millan MT, Palmetshofer A, et al. Thrombin activates nuclear factor-KB and potentiates endothelial cell activation by TNF. J Immunol 1997;159:5620–5628.
  • Rosen T, Kuczynski E, O'Neill LM, et al. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001;10:297–300.
  • Yoon DY, Ma Y, Krikun G, et al. Glucocorticoid effects in the human placenta: evidence that dexamethasone-mediated inhibition of fibronectin expression in cytotrophoblasts involves a protein intermediate. J Chin Endocrinol Metab 1998;83:632–637.
  • Fortunato SJ, Menon R, Swan KF, et al. Organ culture of amniochorionic membrane in vitro. Am J Reprod Immunol 1994;32:184–187.
  • Menon R, Swan KF, Lyden TW, et al. Expression of inflammatory cytokines (interleukin-1 beta and interleukin-6) in amniochorionic membranes. Am J Obstet Gynecol 1995;172:493–500.
  • Vu TK, Hung DT, Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057–1068.
  • Maruyama Y, Maruyama I, Soejima Y. Thrombin receptor agonist peptide decreases thrombomodulin activity in cul-tured human umbilical vein endothelial cells. Biochem Biophys Res Commun 1994;199:1262–1269.
  • Fortunato SJ, Lombardi SJ, Menon R Immunoreactivity of human fetal membranes peptidoglycan polysaccharide (PGPS): cytokine response. J Perinat Med 1998;26:442–447.
  • Auphan N, DiDonato JA, Rosette C, et al. Immunosuppres-sion by glucocorticoids: inhibition of NF-KB activity through induction of IKB synthesis. Science 1995;270:286–290.
  • Rosen T, Schatz F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the mem-branes. J Matern Fetal Neonatal Med 2002;11:11–17.
  • Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004:191: 1996-2001.
  • Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-a in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 2002;187:1159–1162.
  • Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002;346:3719–3727.
  • Lockwood CJ. Predicting premature delivery-No easy task. N Eng J Med 2002;346:282–284.
  • Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-KB and the glucocorticoid receptor. Proc Natl Acad Sci (USA) 1994;91:752–756.
  • Sato H, Seiki M. Regulatory mechanism of 92 kDA type IV collagenase gene expression which is associated with invasive-ness of tumor cells. Oncogene 1993;8:395–405.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.